Immunome (IMNM) Capital Expenditures (2019 - 2026)
Immunome (IMNM) posted Capital Expenditures of $3.0 million for Q1 2026, down 24.93% on a QoQ basis from $4.0 million in Q4 2025, and down 18.09% year-over-year from $3.7 million in Q1 2025.
Immunome (IMNM) Capital Expenditures (2019 - 2026) Analysis & Trends
Immunome's Capital Expenditures history runs 8 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- Quarterly Capital Expenditures fell 18.09% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 million (down 11.93% YoY) and the FY2025 annual result came in at $9.7 million, up 35.02% from the prior year.
- Capital Expenditures was $3.0 million for Q1 2026 at Immunome, down from $4.0 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $4.4 million in Q3 2025 and bottomed at -$2.4 million in Q2 2025.
- A 5-year average of $1.3 million and a median of $408500.0 in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures soared 3616.67% — and 2025, when it tumbled 160.76%.
- Immunome's Capital Expenditures stood at $72000.0 in 2022, then retreated by 20.83% to $57000.0 in 2023, then surged by 1875.44% to $1.1 million in 2024, then soared by 255.15% to $4.0 million in 2025, then dropped by 24.93% to $3.0 million in 2026.
- Business Quant data shows IMNM's Capital Expenditures at $3.0 million in Q1 2026, $4.0 million in Q4 2025, and $4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Immunome | 2.49 Bn | 1.91 Bn | - | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 4.40 Mn |
| Sep 30, 2025 | 4.40 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Mar 31, 2025 | 3.67 Mn |
| Mar 31, 2025 | 3.67 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Mar 31, 2024 | 594,000.00 |
| Mar 31, 2024 | 594,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Dec 31, 2023 | 57,000.00 |